Investor FAQs

Where is Stoke Therapeutics' corporate headquarters?

The Company’s headquarters are located at 45 Wiggins Ave Bedford, MA 01730, USA. The company has an office in Cambridge, MA: 139 Main Street, 4th Floor Cambridge, MA 02142

On what stock exchange are Stoke’s shares traded and what is the ticker?

Stoke’s stock is traded on the NASDAQ Global Select Market under the ticker STOK.

When did Stoke go public?

The Company’s common stock began trading publicly on the NASDAQ Global Market in June 2019.

What is Stoke Therapeutics’ fiscal year?

The Company’s fiscal year ends on December 31.

Does Stoke Therapeutics have a dividend reinvestment plan?

The Company does not currently offer a dividend reinvestment program and does not expect to declare or pay cash or other dividends in our common stock in the foreseeable future.

Who is Stoke Therapeutics' transfer agent?

The transfer agent for the common stock of Stoke Therapeutics is AST.

Does Stoke Therapeutics have a direct stock purchase plan?

Stoke Therapeutics does not currently have a direct stock purchase plan.

Who is Stoke Therapeutics' legal counsel and auditor?

Stoke's legal counsel is:
Fenwick & West, LLP
902 Broadway Suite 14
New York, NY 10010
(212) 921-2001

Stoke's independent auditor is:
1350 6th Ave
New York, NY 10019, USA
(212) 909-5400

Where can I get the latest corporate news releases and financial reports?

Corporate news releases can be found under News on the Investors webpage. Quarterly and annual filings, as well as other SEC filings, can be found in the SEC Filings section of the Investors webpage or directly from the SEC at

How can I obtain a copy of your annual report and proxy?

The Company’s annual report on Form 10K can be found under SEC Filings section of our Investors webpage or directly from the SEC at on our Investor webpage.

When and where will Stoke Therapeutics hold its next annual meeting?

The date and location of the next annual meeting will be communicated prior to the meeting date.